Serum concentrations of sRAGE, a soluble extracellular domain of RAGE that blocks RAGE, are highly correlated in humans with diabetic nephropathy and cardiovascular disease but not yet with human DN [101,102]. Here, AGER is linked to diabetic kidney disease.